NIGP 26987: Therapeutic Agents, Unclassified

NIGP 26987 Therapeutic Agents, Unclassified (Item) encompasses athletic training services, first aid and medical supply procurement, chemical agents for water treatment, and pharmaceutical benefit management programs that state and local governments currently solicit. The code captures a diverse range of deliverables: on-site injury prevention, treatment, and rehabilitation services for public-safety personnel; consumable medical supplies such as bandages, antiseptic sprays, and pain relievers; industrial chemicals including sodium hypochlorite and sulfuric acid for utility operations; and pharmacy benefit administration spanning direct-to-manufacturer prescription fulfillment. Issuing bodies include city fire and police departments (injury prevention and medical supplies), county public works and utility authorities (water treatment chemicals), and state health agencies (pharmaceutical benefit programs). The mix reflects both operational service provision and commodity procurement across municipal, county, and state jurisdictions.

Recent activity spans Arizona, California, and Texas. The City of Tucson posted an RFP in May 2026 seeking comprehensive athletic training services for its Fire and Police Departments on an as-needed basis, with proposals due June 9, 2026; the contract requires NATA BOC and NSCA TSAC-F certified trainers with a minimum three years of professional experience, physician-supervised delivery, and a one-year initial term with four optional one-year extensions. The City of Tampa's Fire Rescue Department issued an ITB in April 2026 for medical aid supplies—a 32-item list including bandages, antiseptic sprays, and first aid kits with estimated annual quantities ranging from 1 to 2,700 units—with a $100,000 departmental budget and set-aside pricing for Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises offering 5 to 8 percent bid discounts. The County of Orange, California posted an IFB in April 2026 for sodium hypochlorite and sulfuric acid with a five-calendar-year contract term effective September 2026, emergency 24-hour delivery capability required, and set-aside preferences for Local Small Businesses and Disabled Veteran Business Enterprises. The Texas Health and Human Services Commission released an RFI in April 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, signaling early-stage state interest in pharmaceutical supply chain restructuring.